This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Beazley PLC | 673.0 | 2.9% |
| IMI PLC | 1,803.0 | 2.2% |
| B&M European Value Retail S.A. | 509.8 | 1.8% |
| Admiral Group PLC | 2,705.0 | 1.3% |
| JD Sports Fashion PLC | 120.0 | 1.1% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Fresnillo PLC | 601.0 | -3.5% |
| BP PLC | 528.2 | -2.0% |
| Centrica PLC | 130.8 | -1.9% |
| BT Group PLC | 105.2 | -1.8% |
| Shell PLC | 2,886.0 | -1.7% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,966 | -0.4% | 1.2% |
| DOW JONES INDUS. AVG | 37,735 | -0.7% | 11.4% |
| DAX INDEX | 18,027 | 0.5% | 14.0% |
| NIKKEI 225 | 38,471 | -1.9% | 35.0% |
| S&P/ASX 200 INDEX | 7,613 | -1.8% | 3.4% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 85.72 | 0.36% |
| Brent Crude (ICE) | USD/bbl. | 90.38 | 0.31% |
| Gold Spot | USD/t oz. | 2,369 | -0.6% |
| Copper (Comex) | USd/lb. | 433 | -1.2% |
Click graph to enlarge
The UK 100 called to open -100 points at 7,865. The UK 100 looks set to open sharply lower this morning as tensions between Israel and Iran continue to spook global markets. On today’s macroeconomic calendar, the UK unemployment rate came in higher than anticipated at 4.2%, when analysts had expected a flat 4%. Stocks retreated on Wall Street yesterday as rising yields and worries over the conflict in the Middle East overshadowed strong Goldman Sachs earnings and hot retail sales data. The Dow Jones lost 248.13 points, or 0.65%, to close at 37,735.11. The 30-stock index relinquished an advance of more than 1% seen early in the session to mark its sixth straight losing day, a streak not seen since June. The S&P slipped 1.2% to finish at 5,061.82, despite trading up as much as 0.88% earlier in the session. The Nasdaq tumbled 1.79% to 15,885.02 as Salesforce and other technology stocks dropped.
AstraZeneca says their drug Imfinzi plus chemotherapy has doubled the overall survival rate in some patients.
DS Smith agrees to merger offer with International Paper.
GSK notes that the FDA has accepted its meningitis vaccine candidate file. They also state that the FDA prescription drug user fee act is set for Feb 2025.
Vodafone says Marika Auramo will be their new CEO of Vodafone Business from July 1st.
Barclays Downgrades Phoenix Group Holdings to Underweight from Overweight (5 Buys / 3 Holds / 1 Sell)
HSBC Upgrades Savills to Buy from Hold (1 Buy / 2 Holds / 0 Sells)
RBC Upgrades Admiral Group to Outperform from Sector Perform (2 Buys / 7 Holds / 2 Sells)
UK
IntegraFin Holdings
Ninety One
Oxford Instuments
QinetiQ
US
Bank of America Corp
Johnson & Johnson
Morgan Stanley
UnitedHealth Group
UK
Hays
Rio Tinto
Saga
US
None
Fed’s Daly speech
IMF Meeting
Chinese Gross Domestic Product
Chinese Industrial Production
Chinese Retail Sales
UK Average Earnings
UK Claimant Count
UK Employment Change
UK ILO Unemployment Rate
German ZEW Survey – Current Situation
German ZEW Survey – Economic Sentiment
EU ZEW Survey – Economic Sentiment
US Building Permits
US Housing Starts
US Industrial Production
BoE’s Governor Bailey speech
Japanese Exports
Japanese Imports
Japanese Trade Balance
UK 100 companies going ex-dividend on 18th April 2024:
Antofagasta
BAE Systems
Unite Group
Croda International
London Stock Exchange Group
Weir Group
Fresnillo
UK 250 companies going ex-dividend on 18th April 2024:
Jupiter Fund Management
Drax Group
Vesuvius
Serco Group
Rotork
Quilter
Rathbones Group
Kier Group
Bridgepoint Group
Dowlais Group
JPMorgan American Investment Trust
Merchants Trust
TwentyFour Income Fund
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.